Revised Tax Disclosure Rules Eliminate the Reporting of Confidential Licensing and Other Intellectual Property Transactions

Revised Tax Disclosure Rules Eliminate the Reporting of Confidential Licensing and Other Intellectual Property Transactions

Publication

Authors

Related Solutions

We help companies protect data, comply with evolving regulations, and respond to investigations and litigation.
A deep and diverse practice focused on maximizing tax efficiencies and minimizing tax risks for clients nationally and internationally.
We leverage technical knowledge, business acumen and legal experience to structure, prepare and negotiate innovative and effective technology-related agreements.
For companies in the life sciences sphere, licensing intellectual property and establishing strategic alliances are critical. WilmerHale’s experienced licensing lawyers shepherd biotech, pharmaceutical, healthcare and medical device clients of all sizes through the complex transactions that make their businesses possible, including a broad range of licensing, collaboration, strategic alliance and joint venture agreements. Our attorneys also excel at brokering manufacturing and supply agreements, contract research and development agreements, distribution and commercialization services agreements, and material transfer and confidentiality agreements. They also frequently represent life sciences clients as they license patents—often the foundations of their companies—from, and sponsor research at, leading academic institutions across the United States and Europe. Backed not only by their own experience but also the deep well of knowledge possessed by the firm’s patent, tax, antitrust and EU competition lawyers, our transactional attorneys are ready to handle even the most multifaceted matters. Our team helps clients protect their innovations, forge strategic alliances, and successfully navigate a complex, dynamic industry.
Our clients in the ever-changing and fiercely competitive hardware, software, IT and services industries depend on us to strategize and negotiate transactions that take advantage of opportunities now while protecting their innovations and preserving flexibility for the future. We structure, negotiate and draft all types of licensing, distribution, product development, joint venture and strategic alliance agreements for these clients, often drawing on the deep experience of WilmerHale’s unique capabilities in regulatory, intellectual property, corporate and tax law. We represent both mature and emerging companies with business models centered around offering software and/or professional services relating to analyzing and extracting insights from large data sets. We frequently draft and negotiate data license agreements, software-as-a-service (SaaS) agreements, website terms and other services agreements in which data is the core subject of the license. We also advise technology clients on big data issues that arise in outsourcing, joint venture and other transactional matters. Our attorneys keep a close watch on internet-related legislative and regulatory developments in the United States, the European Union and elsewhere, and leverage our up-to-the-minute knowledge to advise clients in areas such as data privacy and security, copyright infringement, and export restrictions.
Providing comprehensive solutions for the acquisition, enforcement and protection of IP.

In our Internet Alert of May 14, 2003 we described new Internal Revenue Service (IRS) regulations that imposed new tax reporting requirements with respect to certain "reportable transactions." These regulations were aimed at potentially abusive tax shelters, but included many routine licensing and other intellectual property transactions (as well as many other types of transactions) that are subject to confidentiality restrictions. Many practitioners (including Hale and Dorr) submitted critical comments to the IRS and urged that the regulations be modified.

On December 29, 2003, the IRS responded by issuing revised final regulations pursuant to which most routine transactions will no longer be reportable transactions, even if the parties agree to keep them confidential. Under the revised regulations, a transaction is considered a reportable confidential transaction only if both of the following conditions are satisfied:

  1. the taxpayer pays an advisor a fee for the transaction of at least $250,000 if the taxpayer is a corporation (or a partnership or trust that has only corporations as owners or beneficiaries), or $50,000 in all other cases; and
  2. the advisor places a limitation on disclosure by the taxpayer of the tax treatment or tax structure of the transaction and the limitation on disclosure protects the confidentiality of that advisor's tax strategies.

The new final regulations apply to transactions entered into on or after December 29, 2003, but may be relied upon for transactions entered into on or after January 1, 2003 (the effective date of earlier versions of the regulations). As a result, routine commercial transactions that were reportable as confidential transactions under the previous version of the final regulations will not have to be reported to the IRS after all. In addition, in most cases, there is no longer any need to include in confidentiality agreements waivers authorizing the disclosure of tax structure or tax treatment in order to avoid a reporting obligation.

No other changes were made to the tax shelter reporting regulations. Accordingly, certain other types of transactions remain subject to the reporting requirements, such as transactions that are the same as or substantially similar to abusive transactions identified by the IRS (so-called "listed transactions"). To date, none of the "listed transactions" involve licensing or other intellectual property transactions.

William C. Benjamin
[email protected]

David Grasso
[email protected]

Authors

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel